Nuclear Medicine: Page 66

FDA to review Blue Earth's Axumin for brain cancer

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has accepted molecular imaging firm Blue Earth Diagnostics' supplemental new drug application for the use of its Axumin (fluciclovine F-18) PET radiopharmaceutical in brain cancer detection.

December 10, 2018

South Africa purges board of NECSA nuclear agency

By AuntMinnie.com staff writers

The South African government last week dismissed the entire board of South African Nuclear Energy (NECSA), the federal agency that regulates the production of medical radioisotopes in the country.

December 10, 2018

PET tracers help guide breast cancer therapies

By Kate Madden Yee

PET imaging tracers that track breast cancer enzymes could help guide treatment of the disease, especially in women with BRCA mutations and triple-negative subtypes of cancer, according to two studies presented this week at the 2018 San Antonio Breast Cancer Symposium.

December 6, 2018

PET shows efficacy of tuberculosis meningitis drug

By AuntMinnie.com staff writers

With the help of PET scans, researchers at Johns Hopkins Medicine are gathering information on why the drug rifampin is not very effective in treating tuberculosis meningitis of the brain. They reported their results in a study published online December 5 in Science Translational Medicine.

December 6, 2018

Navidea gets patent extension for Lymphoseek

By AuntMinnie.com staff writers

Radiopharmaceutical developer Navidea Biopharmaceuticals has received a patent extension for its Lymphoseek radiopharmaceutical.

December 6, 2018

New PET tracer could better connect tau to Alzheimer's

By Wayne Forrest

Clinicians may soon have a new PET tracer to improve the detection of tau protein tangles in the brain, advancing the diagnosis of Alzheimer's disease and subsequently leading to more effective treatments for dementia, according to a study published in the December issue of the Journal of Nuclear Medicine.

December 6, 2018

TOF PET/MRI makes dose reduction viable for breast cancer

By Wayne Forrest

Can clinicians use as little as 10% of the conventional FDG dose and still produce diagnostic-quality images to detect breast cancer? Absolutely. It's feasible using a time-of-flight (TOF) imaging technique with PET/MRI, according to a study published in the December issue of the Journal of Nuclear Medicine.

December 6, 2018

Spectrum Dynamics files lawsuit against GE

By Brian Casey

Molecular imaging technology developer Spectrum Dynamics has filed a lawsuit against GE Healthcare, charging GE with "theft and misappropriation" of its trade secrets and intellectual property regarding digital SPECT technology.

December 5, 2018

AuntMinnie.com Molecular Imaging Insider

By Wayne Forrest

December 4, 2018

Subtle Medical scores FDA OK for AI-based PET software

By AuntMinnie.com staff writers

Imaging artificial intelligence (AI) start-up Subtle Medical has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its SubtlePET AI algorithm.

December 4, 2018

Korean society blames low PET fees for nuclear medicine disinterest

By AuntMinnie.com staff writers

The Korean Society of Nuclear Medicine is blaming reductions in FDG-PET reimbursement for physicians' lack of interest in applying for nuclear medicine specialist training positions at the country's 51 major university hospitals.

December 4, 2018

Motion correction technique aids PET thoracic imaging

By Wayne Forrest

To combat poor image results from patient motion in cardiac PET scans, researchers from the U.S. and U.K. have developed an automated retrospective image reconstruction method that greatly reduces the unwanted effects, according to a study published online November 15 in the Journal of Nuclear Medicine.

December 4, 2018

Previous Page

Page 66 of 440

Next Page